Disease-associated marked hyperalphalipoproteinemia

Abstract

Marked hyperalphalipoproteinemia (HAL) is a heterogeneous syndrome. To clarify the pathophysiological significance of HAL, we compared clinical profiles between marked HAL subjects with and without cholesteryl ester transfer protein (CETP) deficiency. CETP deficiency was associated with cardiovascular diseases and strokes in the HAL population, particularly in female. HAL women without CETP deficiency tended to have higher prevalence with cancer history. HAL may not always be a longevity marker, but be sometimes accompanied with pathological conditions.

Keywords

• Atherosclerosis
• Cardiovascular disease
• Cholesteryl ester transfer protein deficiency
• High density lipoprotein
• Hyperalphalipoproteinemia
• Stroke